Biomaterials Market is Estimated to Value Over USD 208 Billion By 2026

  • 20 Aug 2019

The global biomaterials market is anticipated to value over USD 208 billion at a CAGR of over 14.2% during the forecast period 2019 to 2026.

Biomaterials are mostly biological implants for therapeutic or diagnostic purposes. Some of the biomaterials are sutures, metallic joints, heart valves, tendons and so on. The biomaterials have become a vital tool in the medical sector and have demand across the globe. This has resulted in the biomaterials market growth.

Rise in cardiovascular, orthopedic patient population is the key driver for biomaterials market growth and is influencing the CAGR positively. The efficacy of biomaterials in therapeutics and diagnostics is rising its preference by end-users.

Natural biomaterials are anticipated to have a good margin in the market. The reduced risk of adverse effects, contamination and so on are the key factors for the rising demand for biomaterials in not only pharmaceutical but also in the cosmeceutical industry.

The increased number of cardiac, orthopaedic and dental patients is one of the major factors influencing the growth of the biomaterials market across the globe. The cases of cardiac and orthopaedic implants are more as compared to others. Dental implants are also in demand for general treatments as well as for cosmeceutical purposes.

The rising risk of cardiac diseases due to obesity and lifestyle habits is the driving force for North America and the Asia Pacific to dominate the biomaterials market. Furthermore, the major key players in the market have a widespread business in these regions.

The major key players are Royal DSM, BASF SE,  Corbion Berkeley Advanced Biomaterials, Inc., Cam Bioceramics B.V. and so on. Royal DSM is one of the dominating competitors of the biomaterials market. It has a range of advanced biomaterial products for cardiac, orthopaedic, ophthalmologic, etc medical conditions.

FutureWise Key Takeaways:

  • Investment in cardiac and orthopaedic biomaterials marketing
  • Focus on natural biomaterials research

Competitive Landscape:

  • Tier 1 players- established companies in the market
  • Laboratories and Agilent Technologies, Inc. with a major market share 
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

Global Biomaterials Market Segmentation:

By Type:

  • Metallic
  • Polymeric
  • Ceramic
  • Natural biomaterials

By Application:

  • Cardiovascular
  • Orthopaedic
  • Ophthalmology
  • Dental
  • Plastic surgery
  • Wound healing
  • Tissue engineering
  • Neurological/ central nervous system applications
  • Other applications

By Region:

Objectives of the Study:

  • To provide with an exhaustive analysis on the biomaterials market by type, by application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific and Europe
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions 
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Get unlimited analyst support and customise this study further to your requirements, contact